Analysen von Jessica Fye
| 10.03.25 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 27.01.25 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 18.12.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 11.12.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 15.11.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 15.11.24 | Halozyme Therapeutics Neutral | JP Morgan Chase & Co. | |
| 05.11.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 16.09.24 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 13.09.24 | Moderna Underweight | JP Morgan Chase & Co. | |
| 09.09.24 | BioNTech (ADRs) Underweight | JP Morgan Chase & Co. | |
| 16.08.24 | BioNTech (ADRs) Underweight | JP Morgan Chase & Co. | |
| 30.10.23 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 11.01.23 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 21.11.22 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |
| 24.10.22 | BioNTech (ADRs) Neutral | JP Morgan Chase & Co. | |